Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy

Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days

Socioeconomic Deprivation Linked to Worse Survival in Cancer Trials

Overall, progression-free, and cancer-specific survival worse for participants from areas with highest socioeconomic deprivation

Immediate Start of ART for HIV May Impact 10-Year Risk for Cancer

Deferral of antiretroviral therapy may lead to small increase in risk for AIDS-defining cancer

COVID-19 Impacting Caregivers of Children With Cancer

Changes to medical care, financial disruptions, and emotional distress reported

Globalization of Cancer Trials Tied to Lower Enrollment of Blacks

Significant inverse correlation identified between proportion of patients enrolled outside the U.S. and disparity score

Ambulatory Function Poorer for Older Cancer Survivors

Poorer ambulatory function associated with increased risks for mortality; significant associations seen for nine cancer types

Pediatric Oncology Services Disrupted During Pandemic

Newly diagnosed pediatric cancer cases decreased in 43 percent of centers; treatment abandonment increased in 34 percent

ASH Issues Guidance for Preventing, Treating VTE in Cancer

Use of thromboprophylaxis not recommended for ambulatory patients at low risk for VTE who are receiving chemotherapy

Mortality Gap Between Cancer, Heart Disease Narrowing for Women Younger Than 65

Age-adjusted mortality rates decreased for cancer and heart disease from 1999 to 2018, but increased for heart disease from 2010

Vascular Deaths Down for Diabetes Patients in the U.K.

Cancer is now the leading contributor to death among individuals with diabetes living in England